MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Keryx Biopharmaceuticals Company Profile (NASDAQ:KERX)

Consensus Ratings for Keryx Biopharmaceuticals (NASDAQ:KERX) (?)
Ratings Breakdown: 2 Sell Rating(s), 4 Hold Rating(s), 8 Buy Rating(s)
Consensus Rating:Hold (Score: 2.43)
Consensus Price Target: $10.18 (70.75% upside)

Analysts' Ratings History for Keryx Biopharmaceuticals (NASDAQ:KERX)
Show:
DateFirmActionRatingPrice TargetActions
4/30/2016Morgan StanleyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016FBR & Co.Reiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016BTIG ResearchReiterated RatingSell$2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Maxim GroupReiterated RatingBuy$5.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$19.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Brean CapitalReiterated RatingBuy$18.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Stifel NicolausBoost Price TargetBuy$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016Raymond JamesUpgradeMarket Perform -> Outperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2016JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Citigroup Inc.Lower Price Target$2.50 -> $1.80View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015Roth CapitalDowngradeBuy -> Neutral$11.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015MLV & Co.Reiterated RatingBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015MizuhoLower Price TargetBuy$25.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2015OppenheimerLower Price TargetOutperform$22.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014HC WainwrightReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/3/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha